Posted 10.07.17 by admin
Clinical research in haematology is improving treatment and services for people in the North East and North Cumbria
We are active in research across a number of areas of haematology care in both adults and children:
We are actively looking for people to join us in research activity across our region. Information about our team members and the studies in our region are available below.
Clinical lead and Consultant Haematologist at Newcastle Hospitals NHS Foundation Trust: Clinical lead, Dr Tina biss, 0191 2824743, firstname.lastname@example.org;
Clinical lead at Northumbria Healthcare NHS Foundation Trust: Dr Rachel Wells, email@example.com
Clinical lead at City Hospitals Sunderland NHS Foundation Trust: firstname.lastname@example.org
Senior Research nurse at Newcastle Hospitals NHS Foundation Trust: Tel: 0191 2448767 email: email@example.com
Senior research nurse at City Hospitals Sunderland NHS Foundation Trust email: firstname.lastname@example.org
Clinical lead at South Tees Hospitals NHS Foundation Trust. email: email@example.com
Senior research nurse at South Tees Hospitals NHS Foundation Trust. Catherine Laven: email: firstname.lastname@example.org
Senior research nurse at Northumbria Healthcare Trust: Catherine.Ashbrook-Raby@northumbria-healthcare.nhs.uk Tel: 0191 2934094.
Select a trial from the list below to find out more about what it’s all about and how you can get involved in helping others.
The study is for patients with cancer who have been on a blood-thinner for a new clot for less than 3 days (and fit other criteria).
This is a registry study that is aiming to recruit hundreds of individuals with ITP within the UK.
The main aims of this project are to try and understand why some children with a low platelet count bleed, when there is a need for treatment and how having ITP impacts on the quality of life on the child and family.
The information from this study may help us to increase our understanding and improve future treatment for patients with TTP.
The study is for patients who have anaemia for which no cause has been found.
The aim is see if rivaroxaban is as good at treating and preventing recurrence of blood clots in children as standard treatment (warfarin or heparin). The study will also see if rivaroxaban causes less or more bleeding than standard treatment.
Options for the treatment of thrombosis (blood clots) in children are limited. Anticoagulant (blood-thinning) therapy can either be with a tablet called warfarin which needs monitoring with regular blood tests, or a daily injection of heparin. Rivaroxaban is an anticoagulant that can be given as a tablet or syrup and does not need monitoring.
A prospective, international, longitudinal, observational disease registry of patient-reported outcomes (PROs), and clinical impact of Haemophilia A and its treatment in patients with moderate to severe Haemophilia A.
This study will observe feelings when discussing PK guided dosing with patients in the clinic & the process of discussing their own, personal PK profile after a brief educational session.
Find out about clinical trials taking part right here in the North East and North Cumbria
Don’t take it from us. We have real people from our region telling you about their clinical trial experience
Here you can register your interest in clinical trials and start making a difference today
Posted 10.07.17 by admin
Posted 31.03.17 by admin